Contraindications. Mechanical obstruction, perforation, gastrointestinal haemorrhage, phaeochromocytoma (metoclopramide), prolactinoma, QT prolongation or use with strong CYP3A4 inhibitors (domperidone), Parkinson disease (metoclopramide).
Adverse effects. Metoclopramide: acute dystonia, akathisia, parkinsonism, tardive dyskinesia (boxed warning, often irreversible, risk rises with duration), neuroleptic malignant syndrome, hyperprolactinaemia, depression, methaemoglobinaemia in neonates. Domperidone: QT prolongation and sudden cardiac death. Prucalopride: headache, diarrhoea, abdominal pain.
Interactions. Metoclopramide with antipsychotics, SSRIs (serotonin syndrome) and levodopa; it also speeds paracetamol absorption and lowers digoxin absorption. Domperidone with ketoconazole, clarithromycin, erythromycin and other QT drugs.
Special groups.
- Kidney impairment: halve metoclopramide when creatinine clearance is under 60 mL/min and reduce further when severe.
- Children and young adults: dystonia risk is highest; metoclopramide is second-line only.
- Pregnancy: metoclopramide acceptable.
- Breastfeeding: metoclopramide raises prolactin; small milk transfer.
- Older adults: lower doses; watch for parkinsonism.
Monitoring. Abnormal movements, mood, ECG and electrolytes for domperidone.
Referral and escalation. Stop at first dystonia; give procyclidine 5 to 10 mg intramuscularly or intravenously. Refer gastroparesis not controlled by diet and one prokinetic.